首页> 外国专利> CHIMERIC OR HUMANIZED MONOCLONAL ANTIBODY OR F(AB')2 OR FAB FRAGMENTS THEREOF, SINGLE CHAIN ANTIBODY OR SINGLE DOMAIN ANTIBODY CAPABLE OF BINDING TO HUMAN NOGOA POLYPEPTIDE HUMAN NOGO.A_623-640 AND USE THEREOF IN THE PREPARATION OF MEDICAMENTS FOR THERAPY

CHIMERIC OR HUMANIZED MONOCLONAL ANTIBODY OR F(AB')2 OR FAB FRAGMENTS THEREOF, SINGLE CHAIN ANTIBODY OR SINGLE DOMAIN ANTIBODY CAPABLE OF BINDING TO HUMAN NOGOA POLYPEPTIDE HUMAN NOGO.A_623-640 AND USE THEREOF IN THE PREPARATION OF MEDICAMENTS FOR THERAPY

机译:嵌合或人类单克隆抗体或F(AB')2或FAB片段,可与人NOGOA多肽人类NOGO.A_623-640结合的单链抗体或单域抗体,并在制备物中使用它们

摘要

This invention relates to molecules, such as for example monoclonal antibodies or Fab fragments thereof, which are capable of binding to the human NogoA polypeptide or human NiG or human NiG- or human NogoA_623-640 with a dissociation constant 1000 nM; polynucleotides encoding such a binding molecule; an expression vector comprising such polynucleotides; the use of such a binding molecule in the treatment of nerve repair, a pharmaceutical composition comprising such a binding molecule; and to a method of treatment of diseases associated with nerve repair.
机译:本发明涉及能够以<1000nM的解离常数结合人NogoA多肽或人NiG或人NiG-或人NogoA_623-640的分子,例如单克隆抗体或其Fab片段。编码这种结合分子的多核苷酸;包含此类多核苷酸的表达载体;所述结合分子在神经修复治疗中的用途,所述药物组合物包含所述结合分子;以及与神经修复有关的疾病的治疗方法。

著录项

  • 公开/公告号IL169018A

    专利类型

  • 公开/公告日2012-07-31

    原文格式PDF

  • 申请/专利权人 NOVARTIS AG;UNIVERSITAT ZURICH;

    申请/专利号IL20050169018

  • 发明设计人

    申请日2005-06-06

  • 分类号C07K14/47;C07K16/18;C12N15/13;

  • 国家 IL

  • 入库时间 2022-08-21 17:24:50

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号